Nasdaq News

As a retiree in the United States, your monthly Social Security checks will likely help you make ends meet. Unfortunately, though, the average monthly check isn't very big, coming in at just $1,503 in 2020.

Brookfield Infrastructure Partners (NYSE: BIP) has been a big winner since it was formed about a decade ago. The infrastructure company's value has risen more than 325% over that time frame. Add in its high-yielding dividend, and the total return is an even more impressive 700

The headlines suggested ViacomCBS (NASDAQ: VIAC) (NASDAQ: VIACA) shares crashed on Thursday, because the company fell short with its fiscal fourth-quarter results. And to be fair, that news certainly helped to prompt sellers into action.

Side hustles are all the rage these days, and they're instrumental in helping millions of Americans boost their savings, pay off debt, and have more money on hand for leisure, large purchases, or everyday bills. But one drawback to having a second income source is that it can ma

What stock will go up the most in 2020? We'd all like to know that one. And it's a question that's a lot easier to ask than to answer. Let's start by looking at the top 10 stocks of 2019 for clues. The No. 1 stock of 2019, Axsome Therapeutics, had a staggering 3,578% return

The higher your credit score, the more borrowing options you'll open up. Having good credit could help you qualify for an affordable mortgage, get approved for a personal loan at a competitive rate, or snag a credit card with awesome perks. It can also make it possible for you t

The following are today's upgrades for Validea's Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that have low P/B and P/E ratios, along with low debt and solid long-term earnings growth.

The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.

The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative

The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.

The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.

The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.

The following are today's upgrades for Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.

The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.

The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.

The monthly benefit you receive from Social Security in retirement is based on your earnings during your 35 highest-paid years in the workforce. But you actually have the power to raise that benefit substantially. All you need to do is delay your filing until age 70 to score the

Gilead Sciences (NASDAQ: GILD) has been getting a lot of attention these days for remdesivir, its possible treatment for the coronavirus, which so far has resulted in more than 2,000 deaths. Even though remdesivir could be a plus for the company if approved, there are still too

By Heather Huhman

Zscaler (NASDAQ: ZS) continues to deliver strong performance. During the past quarter, the cloud cybersecurity specialist posted guidance-beating results, and management raised its full-year outlook. But revenue growth is decelerating and losses are increasing as the company ra

Marathon Oil (NYSE: MRO) has become a cash flow machine over the past two years. The oil company has produced free cash flow after funding growth and paying its dividend in each of the last eight quarters. Overall, it has generated $1.3 billion in excess cash during that time f